Showing results (161-170 of 255) with videos related to

Sort By:
Pageof 26
International Journal of Antimicrobial Agents|May 16, 2019
Valuing antibiotics: The role of the hospital clinicianRobert G Masterton, Matteo Bassetti, Jean Chastre, et al.
Diagnostic Microbiology and Infectious Disease|November 7, 2017
The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogensDavid B Huang, Leonard R Duncan, Robert K Flamm, et al.
Infectious Diseases and Therapy|July 14, 2018
Real-Life Evidence for Tedizolid Phosphate in the Treatment of Cellulitis and Wound Infections: A Case SeriesSergey Shlyapnikov, Arturo Jauregui, Nana N Khachatryan, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2019
Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure InfectionXiaoju Lv, Jeff Alder, Li Li, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2021
The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infectionAnthony M Buckley, Ines B Moura, James Altringham, et al.
Antibodies (Basel, Switzerland)|April 23, 2024
Case Series: Efficacy of Polyclonal Intravenous Immunoglobulin for Refractory Clostridioides difficile InfectionSophie A Ragan, Caitlin Doyle, Neha Datta, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2020
Eravacycline, a novel tetracycline derivative, does not induce Clostridioides difficile infection in an in vitro human gut modelAnthony M Buckley, James Altringham, Emma Clark, et al.
Clinical and Experimental Gastroenterology|August 3, 2017
High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infectionTanya M Monaghan, Ola H Negm, Brendon MacKenzie, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2017
Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of lifeMark H Wilcox, Harblas Ahir, John E Coia, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 30, 2025
Antimicrobial susceptibility testing of Clostridioides difficile: a dual-site study of three different media and three therapeutic antimicrobialsJane Freeman, Ingrid M J G Sanders, Céline Harmanus, et al.
Pageof 26